3 Lessons From The Delaware Bench Bar Conference (Part II)
The goings-on in Delaware are as relevant as ever to patent litigators and their clients.
3 Lessons From The Delaware Bench Bar Conference (Part I)
No other district court other than Texas has as much impact on patent litigation as Delaware.
Gen AI: Your Legal Research Assistant, Not Your Replacement
Here's how you can spend more time practicing law, and less time sorting, sifting, and summarizing.
The Patent Carpool
With the promise of additional 5G functionality for consumer vehicles comes a concomitant focus in the IP world on having a workable 5G patent licensing regime for automakers.
Simplifying The Complex In Patent Cases
The complexity only gets more challenging when damages are present in a patent case.
GSK Patent Suit Aims To Halt Pfizer’s RSV Vaccine For Adults, But Not Infants
GSK claims that Pfizer’s FDA-approved vaccine for respiratory syncytial virus infringes on four patents protecting its own approved vaccine, Arexvy. The patent suit comes with the RSV season approaching.
Infringement Is Infringement Is Infringement?
A precedential Federal Circuit decision issued last week helps define the scope of when res judicata defenses can apply.
The Hidden Threat: How Fake Identities used by Remote Employees Put Your Business at Risk—and How to Defend Against This
Based on our experience in recent client matters, we have seen an escalating threat posed by the Democratic People’s Republic of Korea (DPRK) information technology (IT) workers engaging in sophisticated schemes to evade US and UN sanctions, steal intellectual property from US companies, and/or inject ransomware into company IT environments, in support of enhancing North Korea’s illicit weapons program.
Supremely Important IP Decisions
It is always worth considering what can be learned about the Supreme Court’s view of IP cases when two decisions in such cases are issued on the same day.
An Idea In Place
This dispute should remind companies and their independent contractors of the rules regarding co-inventorship.
The ‘Skinny Labels’ Case Will Have A Huge Impact On The Affordability Of Healthcare
I wish staying healthy could be cheaper.
Restarting The Patent Treasure Hunt
For the purchasers of BlackBerry’s portfolio, the challenge laying ahead is an obvious one.
The Fifth-Year Dilemma: Do I Stay Or Do I Go (In-House)?
How to make the right decision, and why there might be another way to shape a fulfilling legal career on your own terms.
Morning Docket: 03.28.23
* Mayday mayday! Georgia prosecutor has until May 1 to respond to Trump effort to quash grand jury report. Or, in other words, Trump has inadvertently set May 1 deadline for Georgia prosecutors to level charges. [Reuters] * Hold onto your hats, but a commodity with the word "crypto" in the title might have tried to hide from legal oversight. [Bloomberg Law News] * FTC looks to make it harder for companies to ensnare consumers in difficult to leave subscriptions, which is an immensely popular move so I'm looking forward to the partisan flack this will generate. [Corporate Counsel] * When analogies go wrong: Amgen asked the Supreme Court to think of their patents more like a steam engine, prompting Thomas to quip, "It seems as though you’re actually trying to patent the use of steam pressure...." [Courthouse News Service] * "Football, but without helmets" is apparently also fraught with concussion liability. [BBC] * A dive into why representation matters when you're illegally possessing classified documents. [Salon] * Trainee lawyer diverted $100K in client insurance payments to himself to cover gambling losses. [Roll On Friday]
Meta Facing The Patent Music?
Facebook has had lots of luck when it comes to patents, but its luck may have just run out.
Sanofi CEO: We Don’t Have A Leaky Bathtub
In a media briefing during the J.P. Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire.
‘Girls Can’t Get Rich Playing Sports,’ And Other Reasons I Became An Attorney
A look at how representation and the lack thereof shaped the career of a female patent agent turned patent lawyer.
California Dreaming
It will be interesting to see how the impact of this decision reverberates.